• Keine Ergebnisse gefunden

Long COVID-19 study in Fars, Iran

N/A
N/A
Protected

Academic year: 2022

Aktie "Long COVID-19 study in Fars, Iran"

Copied!
2
0
0

Wird geladen.... (Jetzt Volltext ansehen)

Volltext

(1)

Long COVID-19 study in Fars, Iran

Name: Sex: male /female Phone number:

COVID onset date: Length of hospital stay:

Admission at ICU: Yes/No Date of discharge:

Comorbidities: Yes/No Type of comorbidities:

Responder: patient / immediate family member living with the patient

Have experienced any symptoms or complaints or problems during the past week (Any symptoms or complaints or problems that you did not have before your COVID-19, but have persistently had ever since and during the past seven days?) 1. Muscle weakness Yes /No (mild and tolerable-moderate-sever and incapacitating) 2. Muscle pain Yes /No (mild and tolerable-moderate-sever and incapacitating) 3. Joint pain Yes /No (mild and tolerable-moderate-sever and incapacitating) Which join ……

4. Fatigue Yes /No (mild and tolerable-moderate-sever and incapacitating)

5. Sleep difficulty Yes /No (mild and tolerable-moderate-sever and incapacitating) 6. Anxiety Yes /No (mild and tolerable-moderate-sever and incapacitating)

7. Depression Yes /No (mild and tolerable-moderate-sever and incapacitating)

8. Shortness of breath Yes /No (mild and tolerable-moderate-sever and incapacitating) 9. Chest pain Yes /No (mild and tolerable-moderate-sever and incapacitating)

(2)

10. Palpitation Yes /No (mild and tolerable-moderate-sever and incapacitating) 11. Cough Yes /No (mild and tolerable-moderate-sever and incapacitating)

12. Excess sputum Yes /No (mild and tolerable-moderate-sever and incapacitating) 13. Decreased sense of smell Yes /No (mild and tolerable-moderate-sever and incapacitating)

14. Decreased sense of taste Yes /No (mild and tolerable-moderate-sever and incapacitating)

15. Sore throat Yes /No (mild and tolerable-moderate-sever and incapacitating) 16. Headache Yes /No (mild and tolerable-moderate-sever and incapacitating) 17. Dizziness Yes /No (mild and tolerable-moderate-sever and incapacitating) 18. Concentration difficulty Yes /No (mild and tolerable-moderate-sever and incapacitating)

19. Excess sweating Yes /No (mild and tolerable-moderate-sever and incapacitating) 20. Exercise difficulty Yes /No (mild and tolerable-moderate-sever and incapacitating) 21. Walking difficulty Yes /No (mild and tolerable-moderate-sever and incapacitating) 22. Diarrhea Yes /No (mild and tolerable-moderate-sever and incapacitating)

23. Abdominal pain/stomach ache Yes /No (mild and tolerable-moderate-sever and incapacitating)

24. Loss of appetite Yes /No (mild and tolerable-moderate-sever and incapacitating) 25. Skin lesions Yes /No (mild and tolerable-moderate-sever and incapacitating) 26. Please mention other symptoms or complaints ….

27. Have you affected by any chronic medical illness/problem after your COVID-19 resolved (please mention)?...

Referenzen

ÄHNLICHE DOKUMENTE

● Alle boolschen Funktionen lassen sich auf. Kombinationen von NAND und NOR Gattern

A large fraction of patients, after their COVID-19 viral infections, suffer several neu- rological and psychological symptoms of Long COVID-19 for several months, including:

One of the reasons for the reduction of admissions is probably the fear of contagion, accentuated by the alarmistic coverage of the pandemic by the media, especially among patients

By operationalizing concepts and frameworks inspired by the work of Michel Foucault, our analysis has demonstrated how the very norms and procedures through which harmful

By not wearing masks and controlling masks on others, White sociopolitical construction tries to demon- strate White power and superiority over other ethnic people, specifically

The Finnish Institute of International Affairs is an independent research institute that produces high-level research to support political decision-making and public debate

Compared to older American jets, to say nothing of the latest Russian and Chinese fighter designs, the F-35 is looking worse and worse.. "Can't turn, can't climb, can't run,"

Supp Table 5: Characteristics of people without a history of hypertension prescribed ACEI/ARB medication classes and associated severe COVID-19 and mortality based on